Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Donovan

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Inflammatory Bowel Diseases|June 16, 2011
Apoptosis resistance of mucosal lymphocytes and IL-10 deficiency in patients with steroid-refractory Crohn's diseaseRebeca Santaolalla, Josep Mañé, Elisabet Pedrosa, et al.
Molecular Cancer Therapeutics|March 25, 2014
Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancerMercedes Marín-Aguilera, Jordi Codony-Servat, Òscar Reig, et al.
Nature Communications|October 16, 2020
Aberrant methylation underlies insulin gene expression in human insulinomaEsra Karakose, Huan Wang, William Inabnet, et al.
Plos One|April 18, 2025
The assessment of physiotherapy practice is a robust measure of entry-level physiotherapy standards: Reliability and validity evidence from a large, representative sampleAlan Reubenson, Leo Ng, Vidya Lawton, et al.
Science Advances|May 28, 2019
A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancerErdem Bangi, Celina Ang, Peter Smibert, et al.
Gut|February 24, 2022
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classificationCarla Montironi, Florian Castet, Philipp K Haber, et al.
Iscience|March 18, 2021
A Drosophila platform identifies a novel, personalized therapy for a patient with adenoid cystic carcinomaErdem Bangi, Peter Smibert, Andrew V Uzilov, et al.
Nature Communications|October 5, 2017
Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomasHuan Wang, Aaron Bender, Peng Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2016
Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian CancerYing Chen, Sandra Catalina Camacho, Thomas R Silvers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2026
Correction: Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian CancerYing Chen, Sandra Catalina Camacho, Thomas R Silvers, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Inflammatory Bowel Diseases|June 16, 2011
Apoptosis resistance of mucosal lymphocytes and IL-10 deficiency in patients with steroid-refractory Crohn's diseaseRebeca Santaolalla, Josep Mañé, Elisabet Pedrosa, et al.
Molecular Cancer Therapeutics|March 25, 2014
Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancerMercedes Marín-Aguilera, Jordi Codony-Servat, Òscar Reig, et al.
Nature Communications|October 16, 2020
Aberrant methylation underlies insulin gene expression in human insulinomaEsra Karakose, Huan Wang, William Inabnet, et al.
Plos One|April 18, 2025
The assessment of physiotherapy practice is a robust measure of entry-level physiotherapy standards: Reliability and validity evidence from a large, representative sampleAlan Reubenson, Leo Ng, Vidya Lawton, et al.
Science Advances|May 28, 2019
A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancerErdem Bangi, Celina Ang, Peter Smibert, et al.
Gut|February 24, 2022
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classificationCarla Montironi, Florian Castet, Philipp K Haber, et al.
Iscience|March 18, 2021
A Drosophila platform identifies a novel, personalized therapy for a patient with adenoid cystic carcinomaErdem Bangi, Peter Smibert, Andrew V Uzilov, et al.
Nature Communications|October 5, 2017
Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomasHuan Wang, Aaron Bender, Peng Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2016
Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian CancerYing Chen, Sandra Catalina Camacho, Thomas R Silvers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2026
Correction: Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian CancerYing Chen, Sandra Catalina Camacho, Thomas R Silvers, et al.
Pageof 7